Forefront Analytics, LLC Gilead Sciences, Inc. Transaction History

Forefront Analytics, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $18,124 - $20,413	314 Added 8.4%	4,051 $251,000
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $10,136 - $12,701	175 Added 4.91%	3,737 $221,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $7,915 - $8,984	122 Added 3.55%	3,562 $261,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $55,844 - $60,249	-825 Reduced 19.34%	3,440 $243,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $27,292 - $29,820	430 Added 11.21%	4,265 $294,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $33,180 - $37,858	-553 Reduced 12.6%	3,835 $244,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $248,580 - $283,245	4,388 New	4,388 $256,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $170,961 - $214,954	-2,753 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $171,301 - $198,912	2,368 Added 615.06%	2,753 $212,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $24,112 - $30,884	385 New	385 $28,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

Stay updated on Forefront Analytics, LLC with notifications on news.